607
Views
36
CrossRef citations to date
0
Altmetric
Studies in Humans

Daily consumption of red grape cell powder in a dietary dose improves cardiovascular parameters: a double blind, placebo-controlled, randomized study

&
Pages 342-349 | Received 21 Sep 2014, Accepted 17 Dec 2014, Published online: 10 Feb 2015

References

  • Azachi M, Yatuv R, Katz A, Hagay Y, Danon A. 2014. A novel red grape cells complex: health effects and bioavailability of natural resveratrol. Int J Food Sci Nutr 65:848–855
  • Barona J, Aristizabal JC, Blesso CN, Volek JS, Fernandez ML. 2012. Grape polyphenols reduce blood pressure and increase flow-mediated vasodilation in men with metabolic syndrome. J Nutr 142:1626–1632
  • Boban M, Modun D, Music I, Vukovic J, Brizic I, Salamunic I, Obad A, et al. 2006. Red wine induced modulation of vascular function: separating the role of polyphenols, ethanol, and urates. J Cardio Pharmacol 47:695–701
  • Botden IPG, Draijer R, Westerhof BE, Rutten JHW, Langendonk JG, Sijbrands EJG, Danser AHJ, et al. 2012. Red wine polyphenols do not lower peripheral or central blood pressure in high normal blood pressure and hypertension. Am J Hypertens 25:718–723
  • Catalgol B, Batirel S, Taga Y, Ozer NK. 2012. Resveratrol: French paradox revisited. Front Pharmacol 3:1–18
  • Chaves AA, Joshi MS, Coyle CM, Brady JE, Dech SJ, Schanbacher BL, Baliga R, et al. 2009. Vasoprotective endothelial effects of a standardized grape product in humans. Vasc Pharmacol 50:20–26
  • Cheng S, Gupta DK, Claggett B, Sharrett AR, Shah AM, Skali H, Takeuchi M, et al. 2013. Differential influence of distinct components of increased blood pressure on cardiovascular outcomes: from the atherosclerosis risk in communities study. Hypertension 62:492–498
  • Chiva-Blanch G, Arranz S, Lamuela-Raventos RM, et al. 2013. Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies. Alcohol Alcohol 48:270–277
  • Chiva-Blanch G, Urpi-Sarda M, Ros E, Arranz S, Valderas-Martínez P, Casas R, Sacanella E, et al. 2012. Dealcoholized red wine decreases systolic and diastolic blood pressure and increases plasma nitric oxide: short communication. Circ Res 111:1065–1068
  • Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, et al. 2002. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265
  • Cottart CH, Nivet-Antoine V, Beaudeux JL. 2013. Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans. Mol Nutr Food Res 54:7–16
  • Crozier A, Jaganath IB, Clifford MN. 2009. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26:1001–1043
  • Detampel P, Beck M, Krähenbühl S, Huwyler J. 2012. Drug interaction potential of resveratrol. Drug Metab Rev 44:253–265
  • Dohadwala MM, Hamburg NM, Holbrook M, Kim BH, Duess M-A, Levit A, Titas M, et al. 2010. Effects of Concord grape juice on ambulatory blood pressure in prehypertension and stage 1 hypertension. Am J Clin Nutr 92:1052–1059
  • Dohadwala MM, Holbrook M, Hamburg NM, et al. 2011. Effects of cranberry juice consumption on vascular function in patients with coronary artery disease. Am J Clin Nutr 93:934–940
  • Dolinsky VW, Chakrabarti S, Pereira TJ, Oka T, Levasseur J, Beker D, Zordoky B, et al. 2013. Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice. Biochim Biophys Acta 1832:1723–1733
  • Frémont L. 2000. Biological effects of resveratrol. Life Sci 66:663–673
  • Fuhrman B, Volkova N, Coleman R, Aviram M. 2005. Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity. J Nutr 135:722–728
  • Fujitaka K, Otani H, Jo F, Jo H, Nomura E, Iwasaki M, Nishikawa M, et al. 2011. Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment. Nutr Res 31:842–847
  • Gerhauser C. 2013. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges. Top Curr Chem 329:73–132
  • Giner-Chavez BI, Van Soest PJ, Robertson JB, Lascano C, Reed J, Pell A. 1997. A method for isolating condensed tannins from crude plant extracts with trivalent ytterbium. J Sci Food Agric 74:359–368
  • González R, Ballester I, López-Posadas R, Suárez MD, Zarzuelo A, Martínez-Augustin O, Medina FSD. 2011. Effects of flavonoids and other polyphenols on inflammation. Crit Rev Food Sci Nutr 51:331–362
  • Green DJ. 2005. Point: flow-mediated dilation does reflect nitric oxide-mediated endothelial function. J Appl Phys 99:1233–1234
  • Green DJ, Dawson EA, Groenewoud HMM, Jones H, Thijssen DHJ. 2014. Is flow-mediated dilation nitric oxide mediated? A meta-analysis. Hypertension 63:376–382
  • Guerrero RF, García-Parrilla MC, Puertas B, Cantos-Villar E. 2009. Wine, resveratrol and health: a review. Nat Prod Commun 4:635–658
  • Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, et al. 2008. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 88:38–50
  • Huang Y, Su L, Cai X, Mai W, Wang S, Hu Y, Wu Y, et al. 2014. Association of all-cause and cardiovascular mortality with prehypertension: a meta-analysis. Am Heart J 167:160–168
  • Jambrik Z, Venneri L, Varga A, Rigo F, Borges A, Picano E. 2004. Peripheral vascular endothelial function testing for the diagnosis of coronary artery disease. Am Heart J 148:684–689
  • Kurin E, Atanasov AG, Donath O, Heiss EH, Dirsch VM, Nagy M. 2012. Synergy study of the inhibitory potential of red wine polyphenols on vascular smooth muscle cell proliferation. Planta Med 78:772–778
  • Kuvin JT, Mammen A, Mooney P, Alsheikh-Ali AA, Karas RH. 2007. Assessment of peripheral vascular endothelial function in the ambulatory setting. Vasc Med 12:13–16
  • Lapointe A, Couillard C, Lemieux S. 2006. Effects of dietary factors on oxidation of low-density lipoprotein particles. J Nutr Biochem 17:645–658
  • Leibowitz A, Faltin Z, Perl A, Eshdat Y, Hagay Y, Peleg E, Grossman E. 2013. Red grape berry-cultured cells reduce blood pressure in rats with metabolic-like syndrome. Eur J Nutr 53:973–980
  • Lekakis J, Rallidis LS, Andreadou I, Vamvakou G, Kazantzoglou G, Magiatis P, Skaltsounis A-L, Kremastinos DT. 2005. Polyphenols compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur J Cardiovasc Preven Rehabil 12:596–600
  • Li S-H, Tian H-B, Zhao H-J, Chen L-H, Cui L-Q. 2013. The acute effects of grape polyphenols supplementation on endothelial function in adults: meta-analyses of controlled trials. PloS One 8:e69818
  • Magyar K, Halmosi R, Palfi A, Feher G, Czopf L, Fulop A, Battyany I, et al. 2012. Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease. Clin Hemorh Micro 50:179–187
  • Mikstacka R, Rimando A, Ignatowicz E. 2010. Antioxidant effect of trans-resveratrol, pterostilbene, quercetin and their combinations in human erythrocytes in vitro. Plant Foods Hum Nutr 65:57–63
  • Nematbakhsh M, Zolfaghari B, Eshraghi F, Safari T, Pezeshki Z, Sorooshzadeh SM. 2013. The effects of unripe grape extract on systemic blood pressure, nitric oxide production, and response to angiotensin II administration. Pharm Res 5:60–64
  • Pandey KB, Rizvi SI. 2009. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Long 2:270–278
  • Panickar KS, Jang S. 2013. Dietary and plant polyphenols exert neuroprotective effects and improve cognitive function in cerebral ischemia. Recent Pat Food Nutr Agric 5:128–143
  • Queen BL, Tollefsbol TO. 2010. Polyphenols and aging. Curr Aging Sci 3:34–42
  • Ras RT, Zock PL, Zebregs YEMP, Johnston NR, Webb DJ, Draijer R. 2013. Effect of polyphenol-rich grape seed extract on ambulatory blood pressure in subjects with pre- and stage I hypertension. Br J Nutr 110:1–8
  • Räthel TR, Samtleben R, Vollmar AM, Dirsch VM. 2007. Activation of endothelial nitric oxide synthase by red wine polyphenols: impact of grape cultivars, growing area and the vinification process. J Hyperten 25:541–549
  • Renaud S, de Lorgeril M. 1992. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339:1523–1526
  • Riso P, Klimis-Zacas D, Del Bo C, Martini D, Campolo J, Vendrame S, Møller P, et al. 2012. Effect of a wild blueberry (Vaccinium angustifolium) drink intervention on markers of oxidative sterss, inflammation and endothelial function in humans with cardiovascular risk factors. Eur J Nutr 52:949–961
  • Rodrigo R, Gil D, Miranda-Merchak A, Kalantzidis G. 2012. Antihypertensive role of polyphenols. Adv Clin Chem 58:225–254
  • Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, Corrocher R. 1998. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hyperten 16:1267–1271
  • Segura J, Ruilope LM. 2011. Hypertension in moderate-to-severe nondiabetic CKD patients. Adv Chronic Kidney Dis 18:23–27
  • Shechter M, Matetzky S, Arad M, Feinberg MS, Freimark D. 2009. Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure. Eur J Heart Fail 11:588–593
  • Sies H. 2010. Polyphenols and health: update and perspectives. Arch Biochem Biophys 501:2–5
  • Takahashi T, Asano Y, Amiya E, Hatano M, Tamaki Z, Takata M, Ozeki A, et al. 2014. Clinical correlation of brachial artery flow-mediated dilation in patients with systemic sclerosis. Modern Rheumatol 24:106–111
  • Takishima I, Nakamura T, Hirano M, Kitta Y, Kobayashi T, Fujioka D, Saito Y, et al. 2012. Predictive value of serial assessment of endothelial function in chronic heart failure. Int J Cardiol 158:417–422
  • Tangney CC, Rasmussen HE. 2013. Polyphenols, inflammation, and cardiovascular disease. Curr Atheroscler Rep 15:1–10
  • Thandapilly SJ, LeMaistre JL, Louis XL, Anderson CM, Netticadan T, Anderson H. 2012. Vascular and cardiac effects of grape powder in the spontaneously hypertensive rat. Am J Hyperten 25:1070–1076
  • Timmers S, Konings E, Bilet L, Houtkooper RH, Van De Weijer T, Goossens GH, Hoeks J, et al. 2011. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14:612–622
  • Tome-Carneiro J, Gonzalvez M, Larrosa M, Garcia-Almagro FJ, Aviles-Plaza F, Parra S, Yanez-Gascon MJ, et al. 2012a. Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial. Mol Nutr Food Res 56:810–821
  • Tome-Carneiro J, Gonzalvez M, Larrosa M, Yanez-Gascon MJ, Garcia-Almagro FJ, Ruiz-Ros JA, Garcia-Conesa MT, et al. 2012b. One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease. Am J Cardiol 110:356–363
  • Tome-Carneiro J, Larrosa M, Gonzalez-Sarrias A, Tomas-Barberan FA, Garcia-Conesa MT, Espin JC. 2013. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des 19:6064–6093
  • Tsao R. 2010. Chemistry and biochemistry of dietary polyphenols. Nutrients 2:1231–1246
  • van Mierlo LAJ, Zock PL, van der Knaap HCM, Draijer R. 2010. Grape polyphenols do not affect vascular function in healthy men. J Nutr 140:1769–1773
  • Whelan AP, Sutherland WHF, McCormick MP, Yeoman DJ, De Jong SA, Williams MJA. 2004. Effects of white and red wine on endothelial function in subjects with coronary artery disease. Int Med J 34:224–228
  • WHO. 2011. Global status report on noncommunicable disaeses 2010. Geneva: World Health Organization
  • Wong RHX, Berry NM, Coates AM, Buckley JD, Bryan J, Kunz I, Howe PRC. 2013. Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults. J Hyperten 31:1819–1827
  • Wong RHX, Howe PRC, Buckley JD, Coates AM, Kunz I, Berry NM. 2011. Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr Metab Cardiovasc Dis 21:851–856
  • Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D. 2004. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430:686–689
  • Zhu H, Wang X, Dong Y, Treiber FA, Snieder H. 2005. Influence of the eNOS gene on development of blood pressure and left ventricular mass: longitudinal findings in multiethnic youth. Pharmacogenet Genom 15:669–675

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.